3Funakoshi S,gujimoto S,Hamasaki A,et al.Analysis of factors influencing pancreatic beta cell function in Japanese patients with type 2 diabetes:association with body mass index and duration of diabetic exposure.Diabetes Res Clin Pract,2008,82:353-358.
4Torréns JI,Skumick J,Davidow AL,et al.Ethnic differences in insulin sensitivity and beta-cell function in premenopansal or early perimenopausal women without diabetes:the study of Women's Health Across the Nation(SWAN).Diabetes Care,2004,27:354-361.
5Saxena R,Gianniny L,Burtt NP,et al.Common single nucleotide polymorphisms in TCF7L2 arc reprodueibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals.Diabetes,2006,55:2890-2895.
6Nagaya T,Yoshida H,Takahashi H,et al.Increases in body mass index,even within non-obese levels,raise the risk for type 2 diabetes mellitus:a follow-up study in a Japanese population.Diabet Med,2005,22:1107-1111.
7Chiu KC,Martinez DS,Chu A.Comparison of the relationship of age and beta cell function in three ethnic groups.Clin Endocrinol,2005,62:296-302.
8Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome [J]. Endocr Rev, 2000, 21 (6): 697-738.
9LOnnqvist F, Thome A, Nilsell K, et al. A pathogenic role of visceral fat beta 3-adrenoceptors in'obesity [J]. J Clin Invest, 1995, 95 (3): 1109-1116.
10BjOrntorp P. Metabolic difference between visceral fat and subcu- taneous abdominal fat [J]. Diabetes Metab, 2000, 26 (Suppl 3), 10-12.
